Susquehanna Fundamental Investments’s MacroGenics MGNX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-111,280	Closed	-$141K	–	897
2025 Q1	$141K	Buy	111,280 +22,146	+25%	+$57.9K	﹤0.01%	1014
2024 Q4	$290K	Buy	+89,134	New	+$321K	﹤0.01%	949
2024 Q2	$552K	Buy	129,996 +24,209	+23%	+$236K	0.01%	669
2024 Q1	$1.56M	Buy	105,787 +90,619	+597%	+$1.37M	0.07%	271
2023 Q4	$146K	Sell	15,168 -37,228	-71%	-$257K	0.15%	60
2023 Q3	$244K	Hold	52,396	–	–	0.02%	311
2023 Q2	$280K	Hold	52,396	–	–	0.01%	529
2023 Q1	$376K	Sell	52,396 -5,002	-9%	-$30.1K	0.01%	742
2022 Q4	$385K	Buy	+57,398	New	+$315K	0.01%	937

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna Fundamental Investments's MGNX Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 111,280 shares — an estimated $141K sold.

Susquehanna Fundamental Investments first reported a position in MGNX in Q4 2022 and held it in 9 quarters. The position peaked at $1.56M in Q1 2024. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

Susquehanna Fundamental Investments reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 111,280 MacroGenics shares in Q2 2025, an estimated $141K.
Susquehanna Fundamental Investments first reported a position in MacroGenics in Q4 2022 and held it in 9 quarters.
Susquehanna Fundamental Investments's MacroGenics position peaked at $1.56M in Q1 2024.
112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.